Company-wide revenue
Reported revenue in 2021 ¥2.02B Reported revenue in 2025 ¥579.06M
- growth amount
- −¥1.44B
- growth annualized
- -26.8%
- growth total
- -71.3%
Japanese company profile · 4572
Carna Biosciences, Inc.
In its FY2025 public filing, Carna Biosciences, Inc. reports Drug Discovery Support Business, Drug Discovery. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: カルナバイオサイエンス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
Not disclosed or not safely comparable in the available filings.
FY2025 · fiscal year ended December 2025 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Drug Discovery Support Business | ¥579.06M ↗ | 100.0% | −¥50.69M ↗ |
| Drug Discovery | — | — | −¥2.02B ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended December 2025. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Drug Discovery Support Business
- 創薬支援事業
- Drug Discovery
- 創薬事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Drug Discovery Support Business
- 創薬支援事業
- Drug Discovery
- 創薬事業
- Sales
- 売上高
- Operating profit
- 営業利益
What is growing?
What is growing?
Business revenue growth
Drug Discovery Support Business
Reported revenue in 2021 ¥889.53M Reported revenue in 2025 ¥579.06M
- growth amount
- −¥310.47M
- growth annualized
- -10.2%
- growth total
- -34.9%
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended December 2025
The source document may be in Japanese.
Filing ID: S100XSFK
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.